Martin Evans Maxillofacial Limited 09682133 false 2024-08-01 2025-07-31 2025-07-31 The principal activity of the company is Dental practice activities Digita Accounts Production Advanced 6.30.9574.0 true 09682133 2024-08-01 2025-07-31 09682133 2025-07-31 09682133 bus:Chairman 1 2025-07-31 09682133 core:CapitalRedemptionReserve 2025-07-31 09682133 core:RetainedEarningsAccumulatedLosses 2025-07-31 09682133 core:ShareCapital 2025-07-31 09682133 core:CurrentFinancialInstruments 2025-07-31 09682133 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 09682133 core:FurnitureFittingsToolsEquipment 2025-07-31 09682133 bus:SmallEntities 2024-08-01 2025-07-31 09682133 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 09682133 bus:FilletedAccounts 2024-08-01 2025-07-31 09682133 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 09682133 bus:RegisteredOffice 2024-08-01 2025-07-31 09682133 bus:Chairman 2024-08-01 2025-07-31 09682133 bus:Chairman 1 2024-08-01 2025-07-31 09682133 bus:Director1 2024-08-01 2025-07-31 09682133 bus:Director4 2024-08-01 2025-07-31 09682133 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 09682133 bus:Agent1 2024-08-01 2025-07-31 09682133 core:Goodwill 2024-08-01 2025-07-31 09682133 core:FurnitureFittingsToolsEquipment 2024-08-01 2025-07-31 09682133 core:OfficeEquipment 2024-08-01 2025-07-31 09682133 countries:AllCountries 2024-08-01 2025-07-31 09682133 2024-07-31 09682133 bus:Chairman 1 2024-07-31 09682133 core:FurnitureFittingsToolsEquipment 2024-07-31 09682133 2023-08-01 2024-07-31 09682133 2024-07-31 09682133 bus:Chairman 1 2024-07-31 09682133 core:CapitalRedemptionReserve 2024-07-31 09682133 core:RetainedEarningsAccumulatedLosses 2024-07-31 09682133 core:ShareCapital 2024-07-31 09682133 core:CurrentFinancialInstruments 2024-07-31 09682133 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 09682133 core:FurnitureFittingsToolsEquipment 2024-07-31 09682133 bus:Chairman 1 2023-08-01 2024-07-31 09682133 bus:Chairman 1 2023-07-31 iso4217:GBP xbrli:pure

Registration number: 09682133

Martin Evans Maxillofacial Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 July 2025

Martin Evans Maxillofacial Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 7

Martin Evans Maxillofacial Limited

Company Information

Chairman | Mr M Evans

Directors | Miss M Evans Mr J W Evans

Registered office | Ballards Oakmoore Court, Kingswood Road Hampton Lovett Droitwich Worcs WR9 0QH

Accountants | Ballards LLP Chartered AccountantsOakmoore Court Kingswood Road Hampton Lovett Droitwich Worcestershire WR9 0QH

Martin Evans Maxillofacial Limited

(Registration number: 09682133)
Balance Sheet as at 31 July 2025

| Note | 2025 £ | (As restated) 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 2,246 | 2,749
Current assets |  |  |
Debtors | 5 | 459,197 | 194,480
Cash at bank and in hand |  | 216,895 | 317,141
|  | 676,092 | 511,621
Creditors: Amounts falling due within one year | 6 | (89,369) | (58,209)
Net current assets |  | 586,723 | 453,412
Net assets |  | 588,969 | 456,161
Capital and reserves |  |  |
Called up share capital |  | 3 | 3
Capital redemption reserve |  | 1 | 1
Retained earnings |  | 588,965 | 456,157
Shareholders' funds |  | 588,969 | 456,161

For the financial year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 11 February 2026 and signed on its behalf by:

......................................... Mr M Evans Chairman |  |

Martin Evans Maxillofacial Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

1 | General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
Ballards
Oakmoore Court, Kingswood Road
Hampton Lovett
Droitwich
Worcs
WR9 0QH

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Martin Evans Maxillofacial Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Fixtures & fittings | 25% on a reducing basis
Computer equipment | 33% on a reducing basis

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Martin Evans Maxillofacial Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 3).

Martin Evans Maxillofacial Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

4 | Tangible assets

| Furniture, fittings and equipment £ | Total £
Cost or valuation
At 1 August 2024 | 6,798 | 6,798
Additions | 418 | 418
At 31 July 2025 | 7,216 | 7,216
Depreciation
At 1 August 2024 | 4,049 | 4,049
Charge for the year | 921 | 921
At 31 July 2025 | 4,970 | 4,970
Carrying amount
At 31 July 2025 | 2,246 | 2,246
At 31 July 2024 | 2,749 | 2,749

5 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | 37,504 | 43,547
Other debtors | 421,693 | 150,933
| 459,197 | 194,480

6 | Creditors

| 2025 £ | 2024 £
Due within one year |  |
Trade creditors | 37,885 | 2,060
Other creditors | 51,484 | 56,149
| 89,369 | 58,209

Martin Evans Maxillofacial Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

7 | Related party transactions

Transactions with directors

2025 | At 1 August 2024 £ | Advances to director £ | Repayments by director £ | At 31 July 2025 £
Mr M Evans
Directors Loan Account | (112,846) | (530,999) | 270,564 | (373,281)

2024 | At 1 August 2023 £ | Repayments by director £ | At 31 July 2024 £
Mr M Evans
Directors Loan Account | (162,290) | 49,444 | (112,846)